Cloning and characterization of the mouse AP-2ε gene: a novel family member expressed in the developing olfactory bulb

Members of the mammalian AP-2 transcription factor family have critical regulatory roles in many aspects of development and are also implicated in cancer progression. Four AP-2 genes have been previously characterized in mouse and human, encoding the AP-2alpha, AP-2beta, AP-2gamma, and AP-2delta proteins. Here we report the cloning and characterization of the fifth member of the vertebrate AP-2 family, AP-2epsilon. The AP-2epsilon protein is very similar to the other family members in its DNA binding and dimerization domain and also contains conserved proline and aromatic amino acid residues in the activation domain. Consistent with these observations, AP-2epsilon can bind to the GC-rich AP-2 consensus sequence and can dimerize either with itself or with any of the other AP-2 proteins. The AP-2epsilon protein is also able to activate transcription in a binding site-dependent manner. However, the mouse AP-2epsilon gene is distinctive from the other AP-2 genes in its pattern of expression during embryogenesis. Unlike AP-2alpha, AP-2beta, and AP-2gamma, transcripts corresponding to AP-2epsilon are not found in the neural crest and its derivatives. Instead, AP-2epsilon is expressed most prominently in the mitral cell layer of the developing olfactory bulb. A comparison of AP-2 gene family expression in the olfactory system suggests both distinct and overlapping functions for these transcription factors in forebrain development.

[1]  J Ragoussis,et al.  Evidence of a locus for orofacial clefting on human chromosome 6p24 and STS content map of the region. , 1995, Human molecular genetics.

[2]  M. Bar‐eli.  Gene regulation in melanoma progression by the AP-2 transcription factor. , 2001, Pigment cell research.

[3]  H. Schorle,et al.  Transcription Factor Gene AP-2γ Essential for Early Murine Development , 2002, Molecular and Cellular Biology.

[4]  P. Chambon,et al.  AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis , 1996, Mechanisms of Development.

[5]  J. West-Mays,et al.  Ectopic expression of AP-2alpha transcription factor in the lens disrupts fiber cell differentiation. , 2002, Developmental biology.

[6]  T. Lufkin,et al.  Expression of Tfap2d, the gene encoding the transcription factor Ap-2 delta, during mouse embryogenesis. , 2003, Gene expression patterns : GEP.

[7]  D. Sheer,et al.  Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors. , 1996, Genomics.

[8]  M. Nishizawa,et al.  The human transcription factor activation protein-2 gamma (AP-2gamma): gene structure, promoter, and expression in mammary carcinoma cell lines. , 2002, Gene.

[9]  F. Hanaoka,et al.  Distribution of AP-2 subtypes in the adult mouse brain , 1999, Neuroscience Research.

[10]  M. Tainsky,et al.  Coactivator PC4 Mediates AP-2 Transcriptional Activity and Suppresses ras-Induced Transformation Dependent on AP-2 Transcriptional Interference , 1999, Molecular and Cellular Biology.

[11]  P. Mitchell,et al.  DAP-2, the Drosophila homolog of transcription factor AP-2 , 1998, Mechanisms of Development.

[12]  J. Hsuan,et al.  A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. , 1996, Oncogene.

[13]  Trevor Williams,et al.  Requirement for AP-2α in cardiac outflow tract morphogenesis , 2002, Mechanisms of Development.

[14]  M. Tainsky,et al.  The genomic structure of the human AP-2 transcription factor. , 1994, Nucleic acids research.

[15]  P. Mitchell,et al.  The AP-2 transcription factor is required for joint formation and cell survival in Drosophila leg development. , 2001, Development.

[16]  T. Williams,et al.  The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  N. Schaeren-Wiemers,et al.  A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes , 1993, Histochemistry.

[18]  W. Hollander,et al.  Genetic spina bifida occulta in the mouse. , 1976, The American journal of anatomy.

[19]  B. Gelb,et al.  Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus , 2000, Nature Genetics.

[20]  Y. Ouchi,et al.  Elevated blood pressure and craniofaclal abnormalities in mice deficient in endothelin-1 , 1994, Nature.

[21]  R. Tjian,et al.  Positive and negative regulation of transcription in vitro: Enhancer-binding protein AP-2 is inhibited by SV40 T antigen , 1987, Cell.

[22]  T. Katagiri,et al.  Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer , 1999, Genes, chromosomes & cancer.

[23]  Y. Hayashizaki,et al.  Cloning and Characterization of a Novel Mouse AP-2 Transcription Factor, Ap-2δ, with Unique DNA Binding and Transactivation Properties* , 2001, The Journal of Biological Chemistry.

[24]  Trevor Williams,et al.  SELEX and missing phosphate contact analyses reveal flexibility within the AP-2[alpha] protein: DNA binding complex , 1999, Nucleic Acids Res..

[25]  P. Glazer,et al.  Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. , 1998, Cancer research.

[26]  R. Schüle,et al.  Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. , 1995, Development.

[27]  W. El-Deiry,et al.  AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression , 1997, Nature Genetics.

[28]  M. Ohira,et al.  Identification of the small interstitial deletion at chromosome band 1p34–p35 and its association with poor outcome in oligodendroglial tumors , 2002, Genes, chromosomes & cancer.

[29]  Jian Huang,et al.  Overexpression of transcription factor AP-2alpha suppresses mammary gland growth and morphogenesis. , 2003, Developmental biology.

[30]  R. Tjian,et al.  Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. , 1991, Genes & development.

[31]  R. Tjian,et al.  Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. , 1988, Genes & development.

[32]  P. Chambon,et al.  AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells. , 1996, Experimental cell research.

[33]  K. Mori,et al.  Zonal organization of the mammalian main and accessory olfactory systems. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[34]  T. Shioda,et al.  Human CREB-binding Protein/p300-interacting Transactivator with ED-rich Tail (CITED) 4, a New Member of the CITED Family, Functions as a Co-activator for Transcription Factor AP-2* , 2002, The Journal of Biological Chemistry.

[35]  S. Finkelstein,et al.  Genotypic analysis of primary and metastatic cutaneous melanoma. , 2003, Cancer genetics and cytogenetics.

[36]  M. Tainsky,et al.  Cloning and characterization of the Drosophila homologue of the AP-2 transcription factor , 1998, Oncogene.

[37]  J. Kere,et al.  Mapping of the second locus for the Van der Woude syndrome to chromosome 1p34 , 2001, European Journal of Human Genetics.

[38]  B. Gelb,et al.  Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation. , 2001, American journal of human genetics.

[39]  W. Birchmeier,et al.  Mechanisms Identified in the Transcriptional Control of Epithelial Gene Expression (*) , 1996, The Journal of Biological Chemistry.

[40]  T. Finger,et al.  Neurobiology of taste and smell , 1987 .

[41]  M. Campillos,et al.  Identification of amino acid residues of transcription factor AP-2 involved in DNA binding. , 2000, Journal of molecular biology.

[42]  J. Rüschoff,et al.  Comparative analysis of AP‐2α and AP‐2β gene expression during murine embryogenesis , 1997 .

[43]  H. Reichert,et al.  Drosophila transcription factor AP-2 in proboscis, leg and brain central complex development. , 2001, Development.

[44]  Yusuke Nakamura,et al.  Correlation of allelic losses and clinicopathological factors in primary breast cancers , 1997, Breast cancer.

[45]  I. Ellis,et al.  Immunohistochemical analysis reveals a tumour suppressor‐like role for the transcription factor AP‐2 in invasive breast cancer , 1999, The Journal of pathology.

[46]  Judith A. Blake,et al.  The Mouse Genome Database (MGD): the model organism database for the laboratory mouse , 2002, Nucleic Acids Res..

[47]  Lisa A. McPherson,et al.  AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs. , 1999, Nucleic acids research.

[48]  W. Wurst,et al.  A role for the EphA family in the topographic targeting of vomeronasal axons. , 2001, Development.

[49]  M. Yanagisawa,et al.  Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p23-p24, the endothelin-2 gene (EDN2) to 1p34, and the endothelin-3 gene (EDN3) to 20q13.2-q13.3. , 1991, American journal of human genetics.

[50]  C. Kaufman,et al.  Dissection of a Complex Enhancer Element: Maintenance of Keratinocyte Specificity but Loss of Differentiation Specificity , 2002, Molecular and Cellular Biology.

[51]  T. Nottoli,et al.  Transcription factor AP-2gamma is essential in the extra-embryonic lineages for early postimplantation development. , 2002, Development.

[52]  M. Bronner‐Fraser,et al.  Amphioxus and lamprey AP-2 genes: implications for neural crest evolution and migration patterns. , 2002, Development.

[53]  A. Perkins,et al.  AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Tainsky,et al.  Characterization of the Activation Domains of AP-2 Family Transcription Factors* , 2000, The Journal of Biological Chemistry.

[55]  K. Strissel,et al.  AP-2alpha transcription factor is required for early morphogenesis of the lens vesicle. , 1999, Developmental biology.

[56]  F. Conquet,et al.  Regulation of main olfactory bulb mitral cell excitability by metabotropic glutamate receptor mGluR1. , 2004, Journal of neurophysiology.

[57]  R. Eddy,et al.  cDNA cloning and chromosomal assignment of the endothelin 2 gene: vasoactive intestinal contractor peptide is rat endothelin 2. , 1991, Genomics.

[58]  K. Ying,et al.  Cloning and characterization of a novel human transcription factor AP-2 beta like gene (TFAP2BL1). , 2002, The international journal of biochemistry & cell biology.

[59]  Jennifer N. Murdoch,et al.  Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator , 2001, Nature Genetics.

[60]  S. Wray,et al.  Transcription factor activator protein-2 is required for continued luteinizing hormone-releasing hormone expression in the forebrain of developing mice. , 2000, Endocrinology.

[61]  A. Nicolas,et al.  Leiomyosarcomas and Most Malignant Fibrous Histiocytomas Share Very Similar Comparative Genomic Hybridization Imbalances: An Analysis of a Series of 27 Leiomyosarcomas , 2001, Laboratory Investigation.

[62]  P. Mitchell,et al.  Alternative mRNAs encode multiple isoforms of transcription factor AP-2 during murine embryogenesis. , 1995, Developmental biology.

[63]  R. Mirsky,et al.  Developmental regulation and overexpression of the transcription factor AP‐2, a potential regulator of the timing of Schwann cell generation , 2001, The European journal of neuroscience.

[64]  R. Buettner,et al.  Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. , 2000, Gene.

[65]  K. Zerres,et al.  Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. , 1997, Genes & development.

[66]  R. Tjian,et al.  Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. , 1991, Genes & development.

[67]  Yusuke Nakamura,et al.  Correlation of allelic loss with poor postoperative survival in breast cancer , 1999, Breast cancer.

[68]  M. Gordon,et al.  Physical and genetic localization of the gene encoding the AP-2 transcription factor to mouse chromosome 13. , 1996, Genomics.

[69]  R. Tjian,et al.  Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. , 1991, Science.

[70]  A. McMahon,et al.  Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2 , 1996, Nature.

[71]  L. Coupland,et al.  Partial deletion of chromosome 1 in a case of acute myelocytic leukemia. , 2002, Cancer genetics and cytogenetics.